Article
Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.
Circulation - 12 Oct 2004
Spiecker Martin, Darius Harald, Hankeln Thomas, Soufi Muhidien, Sattler Alexander M, Schaefer Jürgen R, Node Koichi, Börgel Jan, Mügge Andreas, Lindpaintner Klaus, Huesing Anika, Maisch Bernhard, Zeldin Darryl C, Liao James K
Abstract excerpt
BACKGROUND: Cytochrome P450 (CYP) 2J2 is expressed in the vascular endothelium and metabolizes arachidonic acid to biologically active epoxyeicosatrienoic acids (EETs). The EETs are potent endogenous vasodilators and inhibitors of vascular inflammation. However, it is not known whether genetic polymorphisms of CYP2J2 are associated with increased cardiovascular risks. METHODS AND RESULTS: All 9 exons of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
